how-to-patent-in-europe-epo Inventor Related Topics 
Intepat
DECEMBER 24, 2021
It is still rethinking how to approach and solve challenges in a wide range of sectors. The question then becomes whether these AI-generated inventions are patentable under present patent law. The question then becomes whether these AI-generated inventions are patentable under present patent law. BACKGROUND.
The IPKat
MAY 31, 2023
The US Supreme Court recently ruled in the high profile Amgen versus Sanofi patent dispute. 2021 ), the Supreme Court found Amgen's function and epitope defined PCSK9 antibody patents to lack enablement ( Amgen Inc v Sanofi, No. The patents in dispute in Amgen v Sanofi defined a class of antibodies by their function and epitope.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IP Watchdog
SEPTEMBER 5, 2021
In Part I of this series, we discussed how patent portfolio managers should be careful when generating company-owned prior art or reviewing competitor prior art, and how a patent litigation or licensing campaign can be significantly hamstrung based on how the United States and Europe consider intervening prior art.
The IPKat
DECEMBER 28, 2021
Following on from our IPKat EBA 2021 Year in Review , here is some more festive holiday reading on some of the important decisions to come out of the EPO Boards of Appeal this year. 2021 saw key decisions on claim supremacy, types of antibody claims, the data threshold for second medical use inventions and the AI inventor debate. ??
Fish & Richardson Trademark & Copyright Thoughts
JUNE 14, 2022
Moritz Ammelburg and Peter Fasse examine the patentability requirements and prosecution schemes in the US and Europe and how applicants can prepare applications that will best serve their needs in both jurisdictions. can significantly complicate the coordination of a global patent strategy. PDF copy available.
The IPKat
DECEMBER 24, 2022
As a busy year comes, take the time to settle down with your favourite feline friend, a mince pie and the annual IPKat EPO Boards of Appeal roundup. IPKat has also sifted through the 100s of Boards of Appeal decisions published in 2022, to bring you the most eye-catching and relevant to ongoing EPO practice.
IPilogue
AUGUST 11, 2021
To illustrate, consider how the law taxes activity by a person and a machine differently. As AI continues to improve, it is going to take over an ever-increasing number of tasks that were once only performed by people. This is going to have profound consequences socially, economically, and legally.
Expert insights. Personalized for you.
52 
Let's personalize your content